Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H4YP
|
||||
| Former ID |
DNC010010
|
||||
| Drug Name |
4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530490] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H14O3
|
||||
| Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)CC3=C(C4=CC=CC=C4OC3=O)O
|
||||
| InChI |
1S/C20H14O3/c21-19-16-7-3-4-8-18(16)23-20(22)17(19)12-13-9-10-14-5-1-2-6-15(14)11-13/h1-11,21H,12H2
|
||||
| InChIKey |
UHCUHNQBQRRJOC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [530490] | |
| KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
| PathWhiz Pathway | Vitamin K Metabolism | ||||
| WikiPathways | Estrogen metabolism | ||||
| Oxidative Stress | |||||
| Transcriptional activation by NRF2 | |||||
| NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Aryl Hydrocarbon Receptor Pathway | |||||
| Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
| Metabolism of amino acids and derivatives | |||||
| Aryl Hydrocarbon Receptor | |||||
| Dopamine metabolism | |||||
| Arylhydrocarbon receptor (AhR) signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.